C2N Diagnostics LLC

St. Louis, MO

UEI
TE1NNNXJQCD7
CAGE
56YP1
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4340 Duncan Ave #110, St. Louis, MO 63110, USA
Website
c2n.com
Founded
2007
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Plasma abeta isoform concentrations in cognitively impaired patients at risk for amyloidosis R44AG059489 National Institute on Aging (NIH) $1,972,178
Development of novel assays for measuring concentration and metabolism of TAU in… R43AG043206 National Institutes of Health $161,927
Measuring metabolism of c-terminal fragments of amyloid beta in the human central R44AG034725 National Institutes of Health $947,538

Quick answers

Is C2N Diagnostics LLC registered in SAM.gov?

Yes. C2N Diagnostics LLC's SAM.gov registration is active through March 21, 2027.

What is C2N Diagnostics LLC's most recent federal award?

C2N Diagnostics LLC's most recent federal grant award is Plasma abeta isoform concentrations in cognitively impaired patients at risk for amyloidosis (R44AG059489), from National Institute on Aging (NIH), on May 15, 2018.

On GovTribe

See C2N Diagnostics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login